Ratings by BMO Capital (Do Kim)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/13/2021 Scholar Rock SRRK Maintain Outperform
(N/A)
 
 
  Details
5/13/2021 TCR2 Therapeutics TCRR Maintain Outperform
(N/A)
 
 
  Details
5/11/2021 Rapt Therapeutics RAPT Maintain Outperform
(N/A)
 
 
  Details
5/10/2021 Constellation Pharmaceuticals CNST Maintain Outperform
(N/A)
 
 
  Details
4/30/2021 Vertex VRTX Maintain Outperform
(Outperform)
 
 
  Details
4/30/2021 Morphic Therapeutic MORF Maintain Outperform
(Outperform)
 
 
  Details
4/30/2021 Alnylam Pharmaceuticals ALNY Maintain Market Perform
(Market Perform)
 
 
  Details
4/12/2021 Affimed Therapeutics AFMD Maintain Outperform
(N/A)
 
 
  Details
3/23/2021 Ionis Pharmaceuticals IONS Maintain Outperform
(Outperform)
 
 
  Details
3/18/2021 Halozyme Therapeutics HALO Maintain Outperform
(Outperform)
 
 
  Details
3/11/2021 TCR2 Therapeutics TCRR Maintain Outperform
(N/A)
 
 
  Details
3/10/2021 Affimed Therapeutics AFMD Maintain Outperform
(N/A)
 
 
  Details
3/8/2021 Nuvation Bio Inc NUVB New Coverage Outperform
(N/A)
10.50
(8.64)
-17.71% Details
3/5/2021 Schrodinger SDGR Maintain Outperform
(Outperform)
 
 
  Details
3/1/2021 Morphic Therapeutic MORF Maintain Outperform
(N/A)
 
 
  Details
2/24/2021 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
2/24/2021 Halozyme Therapeutics HALO Maintain Outperform
(N/A)
 
 
  Details
2/18/2021 Rigel Pharmaceuticals RIGL Maintain Outperform
(N/A)
 
 
  Details
2/12/2021 Alnylam Pharmaceuticals ALNY Maintain Market Perform
(N/A)
 
 
  Details
2/3/2021 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
1/25/2021 Fate Therapeutics FATE Maintain Market Perform
(N/A)
 
 
  Details
1/25/2021 Schrodinger SDGR Maintain Outperform
(N/A)
 
 
  Details
1/25/2021 Scholar Rock SRRK Maintain Outperform
(N/A)
 
 
  Details
1/25/2021 AbCellera Biologics ABCL Maintain Outperform
(N/A)
 
 
  Details
1/25/2021 Halozyme Therapeutics HALO Maintain Outperform
(N/A)
 
 
  Details
1/25/2021 Constellation Pharmaceuticals CNST Upgrade Outperform
(Market Perform)
34.50
(33.99)
-1.48% Details
1/25/2021 Alnylam Pharmaceuticals ALNY Downgrade Market Perform
(Outperform)
166.75
(178.94)
7.31% Details
1/12/2021 Halozyme Therapeutics HALO Maintain Outperform
(N/A)
 
 
  Details
1/5/2021 AbCellera Biologics ABCL New Coverage Outperform
(N/A)
40.24
(15.17)
-62.3% Details
11/24/2020 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
11/23/2020 Halozyme Therapeutics HALO Maintain Outperform
(N/A)
 
 
  Details
11/23/2020 Schrodinger SDGR Maintain Outperform
(N/A)
 
 
  Details
11/12/2020 Schrodinger SDGR Maintain Outperform
(N/A)
 
 
  Details
11/10/2020 Scholar Rock SRRK Maintain Outperform
(N/A)
 
 
  Details
11/9/2020 Morphic Therapeutic MORF Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 Retrophin RTRX Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 Fate Therapeutics FATE Maintain Market Perform
(N/A)
 
 
  Details
11/5/2020 Replimune Group REPL Maintain Outperform
(N/A)
 
 
  Details
11/2/2020 VBI Vaccines VBIV Maintain Outperform
(N/A)
 
 
  Details
10/29/2020 Amgen AMGN Maintain Outperform
(N/A)
 
 
  Details
10/27/2020 Scholar Rock SRRK Maintain Outperform
(N/A)
 
 
  Details
10/20/2020 Rapt Therapeutics RAPT Maintain Outperform
(N/A)
 
 
  Details
9/17/2020 Rigel Pharmaceuticals RIGL Maintain Outperform
(N/A)
 
 
  Details
9/1/2020 Checkmate Pharmaceuticals CMPI New Coverage Outperform
(N/A)
15.28
(5.02)
-67.15% Details
9/1/2020 Akcea Therapeutics, Inc. AKCA Downgrade Market Perform
(Outperform)
11.38
(18.17)
59.67% Details
8/14/2020 BioXcel Therapeutics BTAI Maintain Outperform
(N/A)
 
 
  Details
8/13/2020 Rapt Therapeutics RAPT Maintain Outperform
(N/A)
 
 
  Details
8/10/2020 Morphic Therapeutic MORF Maintain Outperform
(N/A)
 
 
  Details
8/10/2020 Schrodinger SDGR Maintain Outperform
(N/A)
 
 
  Details
8/5/2020 Constellation Pharmaceuticals CNST Maintain Market Perform
(N/A)
 
 
  Details
8/3/2020 VBI Vaccines VBIV Maintain Outperform
(N/A)
 
 
  Details
7/31/2020 VBI Vaccines VBIV Maintain Outperform
(N/A)
 
 
  Details
7/31/2020 Vertex VRTX Maintain Outperform
(N/A)
 
 
  Details
7/27/2020 TCR2 Therapeutics TCRR Maintain Outperform
(N/A)
 
 
  Details
7/21/2020 BioXcel Therapeutics BTAI Maintain Outperform
(N/A)
 
 
  Details
7/20/2020 BioXcel Therapeutics BTAI Maintain Outperform
(N/A)
 
 
  Details
7/14/2020 Rigel Pharmaceuticals RIGL Maintain Outperform
(N/A)
 
 
  Details
7/7/2020 ObsEva OBSV Downgrade Market Perform
(Outperform)
6.15
(2.52)
-59.02% Details
6/8/2020 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
6/2/2020 Schrodinger SDGR Maintain Outperform
(N/A)
 
 
  Details
5/14/2020 Schrodinger SDGR Maintain Outperform
(N/A)
 
 
  Details
5/7/2020 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
5/7/2020 VBI Vaccines VBIV Maintain Outperform
(N/A)
 
 
  Details
5/7/2020 Constellation Pharmaceuticals CNST Maintain Market Perform
(N/A)
 
 
  Details
5/6/2020 Constellation Pharmaceuticals CNST Maintain Market Perform
(N/A)
 
 
  Details
5/6/2020 Akcea Therapeutics, Inc. AKCA Maintain Outperform
(N/A)
 
 
  Details
5/1/2020 Amgen AMGN Maintain Outperform
(N/A)
 
 
  Details
4/14/2020 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
3/31/2020 VBI Vaccines VBIV Maintain Outperform
(N/A)
 
 
  Details
3/9/2020 BioXcel Therapeutics BTAI Maintain Outperform
(N/A)
 
 
  Details
3/6/2020 ObsEva OBSV Maintain Outperform
(N/A)
 
 
  Details
3/5/2020 ObsEva OBSV Maintain Outperform
(N/A)
 
 
  Details
3/3/2020 Fate Therapeutics FATE Maintain Market Perform
(N/A)
 
 
  Details
3/2/2020 Schrodinger SDGR New Coverage Outperform
(N/A)
46.38
(67.70)
45.97% Details
2/25/2020 Retrophin RTRX Maintain Outperform
(N/A)
 
 
  Details
2/25/2020 Halozyme Therapeutics HALO Maintain Outperform
(N/A)
 
 
  Details
1/31/2020 Vertex VRTX Maintain Outperform
(N/A)
 
 
  Details
1/31/2020 Amgen AMGN Maintain Outperform
(N/A)
 
 
  Details
1/30/2020 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
1/16/2020 BioXcel Therapeutics BTAI Maintain Outperform
(N/A)
 
 
  Details
1/15/2020 Halozyme Therapeutics HALO Maintain Outperform
(N/A)
 
 
  Details
1/14/2020 Halozyme Therapeutics HALO Maintain Outperform
(N/A)
 
 
  Details
1/9/2020 VBI Vaccines VBIV Maintain Outperform
(N/A)
 
 
  Details
1/9/2020 Vertex VRTX Maintain Outperform
(N/A)
 
 
  Details
1/9/2020 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
1/9/2020 Amgen AMGN Maintain Outperform
(N/A)
 
 
  Details
1/9/2020 Fate Therapeutics FATE Downgrade Market Perform
(Outperform)
21.01
(82.80)
294.1% Details
1/9/2020 Halozyme Therapeutics HALO Upgrade Outperform
(Market Perform)
17.82
(41.33)
131.93% Details
1/9/2020 Constellation Pharmaceuticals CNST Downgrade Market Perform
(Outperform)
40.81
(33.99)
-16.71% Details
12/20/2019 Akcea Therapeutics, Inc. AKCA Maintain Outperform
(N/A)
 
 
  Details
12/10/2019 ObsEva OBSV Maintain Outperform
(N/A)
 
 
  Details
12/9/2019 Rigel Pharmaceuticals RIGL Maintain Outperform
(N/A)
 
 
  Details
12/9/2019 Fate Therapeutics FATE Maintain Outperform
(N/A)
 
 
  Details
11/25/2019 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
11/25/2019 Rapt Therapeutics RAPT New Coverage Outperform
(N/A)
20.70
(30.67)
48.16% Details
11/20/2019 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
11/19/2019 Vertex VRTX Maintain Outperform
(N/A)
 
 
  Details
11/13/2019 Morphic Therapeutic MORF Maintain Outperform
(N/A)
 
 
  Details
11/13/2019 Halozyme Therapeutics HALO Maintain Market Perform
(N/A)
 
 
  Details
11/12/2019 TCR2 Therapeutics TCRR Maintain Outperform
(N/A)
 
 
  Details
11/8/2019 ObsEva OBSV Maintain Outperform
(N/A)
 
 
  Details
11/7/2019 Constellation Pharmaceuticals CNST Maintain Outperform
(N/A)
 
 
  Details
11/7/2019 VBI Vaccines VBIV Maintain Outperform
(N/A)
 
 
  Details
11/6/2019 Akcea Therapeutics, Inc. AKCA Maintain Outperform
(N/A)
 
 
  Details
11/6/2019 Fate Therapeutics FATE Maintain Outperform
(N/A)
 
 
  Details
11/5/2019 Halozyme Therapeutics HALO Maintain Market Perform
(N/A)
 
 
  Details
11/4/2019 Halozyme Therapeutics HALO Maintain Market Perform
(N/A)
 
 
  Details
10/31/2019 Retrophin RTRX Maintain Outperform
(N/A)
 
 
  Details
10/22/2019 Vertex VRTX Maintain Outperform
(N/A)
 
 
  Details
10/21/2019 Vertex VRTX Maintain Outperform
(N/A)
 
 
  Details
10/7/2019 Akcea Therapeutics, Inc. AKCA Maintain Outperform
(N/A)
 
 
  Details
9/30/2019 Amgen AMGN Maintain Outperform
(N/A)
 
 
  Details
9/18/2019 BioXcel Therapeutics BTAI Maintain Outperform
(N/A)
 
 
  Details
9/11/2019 VBI Vaccines VBIV Maintain Outperform
(N/A)
 
 
  Details
9/9/2019 Amgen AMGN Maintain Outperform
(N/A)
 
 
  Details
8/26/2019 Amgen AMGN Maintain Outperform
(N/A)
 
 
  Details
8/23/2019 Retrophin RTRX Maintain Outperform
(N/A)
 
 
  Details
8/22/2019 Retrophin RTRX Maintain Outperform
(N/A)
 
 
  Details
8/13/2019 Morphic Therapeutic MORF Maintain Outperform
(N/A)
 
 
  Details
8/8/2019 ObsEva OBSV Maintain Outperform
(N/A)
 
 
  Details
8/7/2019 Akcea Therapeutics, Inc. AKCA Maintain Outperform
(N/A)
 
 
  Details
8/7/2019 Fate Therapeutics FATE Maintain Outperform
(N/A)
 
 
  Details
8/1/2019 Vertex VRTX Maintain Outperform
(N/A)
 
 
  Details
7/31/2019 Amgen AMGN Maintain Outperform
(N/A)
 
 
  Details
7/23/2019 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
7/22/2019 Morphic Therapeutic MORF New Coverage Outperform
(N/A)
19.22
(57.62)
199.79% Details
7/18/2019 ObsEva OBSV Maintain Outperform
(N/A)
 
 
  Details
6/17/2019 VBI Vaccines VBIV Maintain Outperform
(N/A)
 
 
  Details
5/23/2019 Affimed Therapeutics AFMD Maintain Outperform
(N/A)
 
 
  Details
5/23/2019 BioXcel Therapeutics BTAI Maintain Outperform
(N/A)
 
 
  Details
5/1/2019 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
4/22/2019 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
4/16/2019 Amgen AMGN Maintain Outperform
(N/A)
 
 
  Details
4/15/2019 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
4/8/2019 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
3/27/2019 Affimed Therapeutics AFMD Maintain Outperform
(N/A)
 
 
  Details
3/15/2019 Amgen AMGN New Coverage Outperform
(N/A)
187.35
(241.54)
28.92% Details
3/11/2019 TCR2 Therapeutics TCRR New Coverage Outperform
(N/A)
18.02
(12.44)
-30.97% Details
2/28/2019 Ionis Pharmaceuticals IONS Maintain Outperform
(N/A)
 
 
  Details
2/8/2019 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
2/6/2019 Vertex VRTX Maintain Outperform
(N/A)
 
 
  Details
1/23/2019 Rigel Pharmaceuticals RIGL Maintain Outperform
(N/A)
 
 
  Details
11/27/2018 Halozyme Therapeutics HALO Maintain Market Perform
(N/A)
 
 
  Details
11/9/2018 Scholar Rock SRRK Maintain Outperform
(N/A)
 
 
  Details
11/9/2018 Constellation Pharmaceuticals CNST Maintain Outperform
(N/A)
 
 
  Details
11/8/2018 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
11/8/2018 Affimed Therapeutics AFMD Maintain Outperform
(N/A)
 
 
  Details
11/7/2018 Halozyme Therapeutics HALO Maintain Market Perform
(N/A)
 
 
  Details
11/6/2018 Akcea Therapeutics, Inc. AKCA Maintain Outperform
(N/A)
 
 
  Details
10/25/2018 Vertex VRTX Maintain Outperform
(N/A)
 
 
  Details
8/28/2018 Affimed Therapeutics AFMD Maintain Outperform
(N/A)
 
 
  Details
8/14/2018 Replimune Group REPL New Coverage Outperform
(N/A)
16.91
(32.73)
93.55% Details
8/13/2018 Alnylam Pharmaceuticals ALNY Maintain Outperform
(N/A)
 
 
  Details
8/13/2018 Constellation Pharmaceuticals CNST New Coverage Outperform
(N/A)
9.87
(33.99)
244.38% Details